XML 56 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
EARNINGS PER SHARE
 9 Months Ended
Sep. 30, 2013
Earnings Per Share [Abstract]  
Earnings Per Share
EARNINGS PER SHARE

Income (Loss) Per Share

The following table sets forth the computation of basic and diluted income (loss) per common share (in thousands, except for per share amounts):
 
Three Months Ended 
 September 30,
 
Nine Months Ended 
 September 30,
 
2013
 
2012
 
2013
 
2012
Numerator:
 
 
 
 
 
 
 
Loss from continuing operations, net of income taxes
$
(22,442
)
 
$
(605
)
 
$
(38,229
)
 
$
(6,921
)
(Loss) income from discontinued operations, net of income taxes
(11,645
)
 
(10,931
)
 
(12,866
)
 
64,448

Net (loss) income
$
(34,087
)
 
$
(11,536
)
 
$
(51,095
)
 
$
57,527

 
 
 
 
 
 
 
 
Denominator - Basic:
 

 
 

 
 

 
 

Weighted average number of common shares outstanding
67,912

 
56,640

 
63,368

 
56,019

 
 
 
 
 
 
 
 
Basic loss from continuing operations
$
(0.35
)
 
$
(0.01
)
 
$
(0.61
)
 
$
(0.12
)
Basic (loss) income from discontinued operations
(0.18
)
 
(0.19
)
 
(0.20
)
 
1.15

Basic (loss) income
$
(0.53
)
 
$
(0.20
)
 
$
(0.81
)
 
$
1.03

 
 
 
 
 
 
 
 
Denominator - Diluted:
 

 
 

 
 

 
 

Weighted average number of common shares outstanding
67,912

 
56,640

 
63,368

 
56,019

Common share equivalents of outstanding stock options and restricted awards
—

 
—

 
—

 
—

Total diluted shares outstanding
67,912

 
56,640

 
63,368

 
56,019

 
 
 
 
 
 
 
 
Diluted loss from continuing operations
$
(0.35
)
 
$
(0.01
)
 
$
(0.61
)
 
$
(0.12
)
Diluted (loss) income from discontinued operations
(0.18
)
 
(0.19
)
 
(0.20
)
 
1.15

Diluted (loss) income
$
(0.53
)
 
$
(0.20
)
 
$
(0.81
)
 
$
1.03



Accounting Standards Codification ("ASC") Topic 260, Earnings Per Share, requires that income from continuing operations be used as the basis of determining whether the inclusion of common stock equivalents would be anti-dilutive. Accordingly, the computation of diluted shares for the three months and nine months ended September 30, 2013 and 2012 excludes the effect of the Company's 3.2 million common stock purchase warrants with an exercise price of $10 issued in connection with the acquisition of Critical Homecare Solutions Holdings, Inc. ("CHS") in 2010 as their inclusion would be anti-dilutive to earnings per common share from continuing operations. In addition to the warrants, the computation of diluted shares for the three months and nine months ended September 30, 2013 and 2012 excludes the effect of 6.3 million and 5.4 million shares, respectively, of other common stock equivalents as their inclusion would be anti-dilutive to earnings per common share from continuing operations.